Hyperoxia modulates TGF-β/BMP signaling in a mouse model of bronchopulmonary dysplasia
Miguel A. Alejandre Alcázar(University of Cologne), Rory E. Morty(Heidelberg University), Małgorzata Wygrecka(German Center for Lung Research), Grażyna Kwapiszewska(Cardio-Pulmonary Institute), Werner Seeger(Justus-Liebig-Universität Gießen), Leigh M. Marsh(Ludwig Boltzmann Institute for Lung Vascular Research), Ralph T. Schermuly(Justus-Liebig-Universität Gießen), Bastian Eul(Hals- Nasen- und Ohrenklinik Gießen), Irwin Reiss(Erasmus MC - Sophia Children’s Hospital), J Sevilla-Pérez, Oana V. Amarie(Helmholtz Munich), Oliver Eickelberg(Ludwig-Maximilians-Universität München), Mareike Hesse, S Köbrich
American Journal of Physiology-Lung Cellular and Molecular Physiology
October 28, 2006
Cited by 229
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|784
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777